The Sixth Annual Managed Markets Summit Opens Next Week in Las Vegas

The Sixth Annual Managed Markets Summit Opens Next Week in Las Vegas

<0> Decision Resources GroupBriana Pontremoli, 781-993-2654orDecision Resources GroupElizabeth Marshall, 781-993-2563 </0>

The Sixth Annual Pinsonault Managed Markets Summit kicks off Wednesday, September 19 at The Cosmopolitan of Las Vegas. The three-day conference brings together executives in the managed markets industry to discuss the critical trends affecting healthcare reform, specialty pharmacy, Medicaid and the impact the 2012 presidential election will have on healthcare.

The Managed Markets Summit will feature keynote speeches by:

Additionally, more than fifty breakout sessions are in the conference program lead by industry-leading speakers from the nation’s largest corporations in healthcare. For more information, go to .

The Summit runs September 19-21, 2012. Admission is $2,595 and includes access to all keynote presentations, conference breakout sessions, networking events and meeting materials. Meals and refreshment breaks are also included. Attendees can register online at or onsite at The Cosmopolitan beginning Tuesday, September 18.

For the most up-to-date information including conference happenings, news, videos and buzz follow the Managed Markets Summit on Twitter at .

Media interested in attending the conference should contact Briana Pontremoli at or 781-993-2654 for additional information.

Pinsonault, a division of Decision Resources Group, is dedicated to and focused on delivering high quality, Managed Markets specific, business and training solutions within the pharmaceutical and biotech industries. The organization strives to create customer specific solutions that provide valuable strategic insight and results oriented tactical tools enabling clients to identify and capitalize on Managed Markets business opportunities. For more information, visit .

Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. For more information, visit .

Suggested Articles

Loretta Itri, M.D. has been helping Immunomedics out with its troubled antibody-drug conjugate. Now, she’s signing on as its chief medical officer.

Light Chain Bioscience, a unit of Swiss biotech Novimmune, has been handed a nice royalty milestone check from partner Takeda.

The fund received money from Chinese organizations inside and outside the biopharma industry, enabling CICC Capital to ease past its financing goal.